BioCentury
ARTICLE | Company News

KV Pharmaceutical management update

November 22, 2010 8:00 AM UTC

KV Pharmaceutical Co. (NYSE:KVA), St. Louis, Mo. Business: Drug delivery, Generics Transitioned: Greg Divis to CEO from interim CEO, while remaining the president of KV's Ther-Rx Corp. subsidiary ...